Join Clinical Trials for Healthy Volunteers in Australia

All Categories Healthy Participants » Australia

A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia

Condition: Prostatic Hyperplasia
Interventions: Drug: Dutasteride (0.5mg, fasted state); Drug: Dutasteride (0.5mg, fed state); Drug: Fixed dose combination capsule containing dutasteride 0.5mg and tamsulosin 0.2mg (fasted state); Drug: Fixed dose combination capsule containing dutasteride 0.5mg and tamsulosin 0.2mg (fasted state); Drug: Fixed dose combination capsule containing dutasteride 0.5mg and tamsulosin 0.2mg (fasted state); Drug: Fixed dose combination capsule containing dutasteride 0.5mg and tamsulosin 0.2mg (fed state); Drug: Harnal-D Tablets with water (fasted state); Drug: Harnal-D Tablets with water (fed state); Drug: Harnal-D tablets without water (fasted state)
Sponsor: GlaxoSmithKline
Recruiting - verified December 2011
A Phase 1 Study of PPI-668 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) Genotype 1

Condition: Hepatitis C Virus Infection
Interventions: Drug: PPI-668; Drug: Placebo
Sponsor: Presidio Pharmaceuticals, Inc.
Recruiting - verified February 2012
Safety Study of NNZ-2566 in Healthy Subjects, Following Oral Administration

Condition: Brain Injuries, Traumatic
Interventions: Drug: NNZ-2566; Drug: Placebo
Sponsor: Neuren Pharmaceuticals Limited
Not yet recruiting - verified January 2012
Study To Investigate The Relative Bioavailability of OZ439 Formulations In Healthy Volunteers

Condition: Healthy Volunteers
Intervention: Drug: OZ439
Sponsors: Medicines for Malaria Venture; AMREP Centre for Clinical Studies, Nucleus Network, 89 Commercial Road, Melbourne, VIC 3004 Australia
Not yet recruiting - verified June 2011
Study of Ketamine Administered Intravenously and by Sublingual Wafer

Condition: Pain
Intervention:
Sponsor: IX Biopharma Pte. Ltd.
Recruiting - verified June 2011
Comparison of Measures of Plasticity

Conditions: Depression; Healthy
Interventions: Procedure: cTBS-PAS25; Procedure: cTBS-iTBS; Procedure: PAS25; Procedure: iTBS
Sponsor: The University of New South Wales
Recruiting - verified March 2011
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.

Conditions: Ulcerative Colitis; Crohn's Disease
Interventions: Drug: AMG 181; Other: Placebo for AMG 181
Sponsor: Amgen
Recruiting - verified January 2012
Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects

Condition: Crohn's Disease
Intervention: Drug: AMG 139
Sponsor: Amgen
Recruiting - verified January 2012
The Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study

Condition: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Intervention: Biological: GSK580299 (CervarixTM)
Sponsor: GlaxoSmithKline
Recruiting - verified November 2011
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis

Condition: Ulcerative Colitis
Intervention: Drug: Amg 181
Sponsor: Amgen
Recruiting - verified January 2012